4.6 Article

Genetically predicted 17β-estradiol and systemic inflammation in women: a separate-sample Mendelian randomisation analysis in the Guangzhou Biobank Cohort Study

期刊

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/jech-2013-203451

关键词

-

资金

  1. University of Hong Kong Foundation for Development and Research (Hong Kong, China)
  2. University of Hong Kong University Research Committee Strategic Research Theme of Public Health (Hong Kong, China)
  3. Guangzhou Public Health Bureau (Guangzhou, China)
  4. Guangzhou Science and Technology Bureau (Guangzhou, China)
  5. University of Birmingham (Birmingham, UK)
  6. Research Grant Council General Research Fund [769710]
  7. Research Grant Council of Hong Kong, Hong Kong SAR, People's Republic of China

向作者/读者索取更多资源

Background Many chronic diseases are characterised by low-grade systemic inflammation. Oestrogens may promote immune response consistent with sex-specific patterns of diseases. In vitro culture and animal experiments suggest oestrogens are anti-inflammatory and might thereby protect against low-grade systemic inflammation. Evidence from epidemiological studies is limited. Using a Mendelian randomisation analysis with a separate-sample instrumental variable (SSIV) estimator, we examined the association of genetically predicted 17 beta-estradiol with well-established systemic inflammatory markers (total white cell count, granulocyte and lymphocyte count). Methods A genetic score predicting 17 beta-estradiol was developed in 237 young Chinese women (university students) from Hong Kong based on a parsimonious set of genetic polymorphisms (ESR1 (rs2175898) and CYP19A1 (rs1008805)). Multivariable linear regression was used to examine the association of genetically predicted 17 beta-estradiol with systemic inflammatory markers among 3096 older (50+ years) Chinese women from the Guangzhou Biobank Cohort Study. Results Predicted 17 beta-estradiol was negatively associated with white blood cell count (-6.3 10(3)/mL, 95% CI -11.4 to -1.3) and granulocyte count (-4.5 103/mL, 95% CI -8.5 to -0.4) but not lymphocyte count (-1.5 10(3)/mL, 95% CI -3.4 to 0.4) adjusted for age only. Results were similar further adjusted for education, smoking, use of alcohol, physical activity, Body Mass Index, waist-hip ratio, age of menarche, age at menopause, use of hormonal contraceptives and hormone replacement therapy. Conclusions Endogenous genetically predicted 17 beta-estradiol reduced low-grade systemic inflammatory markers (white blood cell count and granulocyte count), consistent with experimental and ecological evidence of 17 beta-estradiol promoting immune response. Replication in a larger sample is required.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据